Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions

American Journal of Cardiology

Volumn 85, Issue 9, 2000, Pages 1077-1082

  Fuchs, Shmuel ^a   Kornowski, Ran ^a   Mehran, Roxana ^a   Lansky, Alexandra J ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Kent, Kenneth M ^a   Clark, Chester E ^a   Stone, Gregg W ^a   Leon, Martin B ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE ISOENZYME; TROPONIN I;

ADULT; AGED; ARTICLE; ATHERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RISK ASSESSMENT; SAPHENOUS VEIN GRAFT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; CREATINE KINASE; FEMALE; HUMANS; ISOENZYMES; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; SAPHENOUS VEIN; STENTS; TROPONIN I;

EID: 0034192028     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00699-8     Document Type: Article

References (19)

1. Hamm C.W., Katus H.A. New biochemical markers for myocardial cell injury. Curr Opin Cardiol. 10:1995;355-360.
2. Bertinchant J.P., Larue C., Pernel I., Ledermann B., Fabbro-Peray P., Beck L., Calzolari C., Trinquier S., Nigond J., Pau B. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin biochem. 29:1996;587-594.
3. Adams J.E. III, Bodor G.S., Davila-Roman V.G., Delmez J.A., Apple F.S., Ladenson J.H., Jaffe A.S. Cardiac troponin I, a marker with high specificity for cardiac injury. Circulation. 88:1993;101-106.
4. Galvani M., Ottani F., Ferrini D., Ladenson J.H., Destro A., Baccos D., Rusticali F., Jaffe A.S. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 95:1997;2053-2059.
5. Luscher M.S., Thygesen K., Ravkilde J., Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin inhibition in myocardial ischemia. Circulation. 96:1997;2578-2585.
6. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., Fischer G.A., Fung A.Y., Thompson C., Wybenga D., Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.
7. Shyu K.G., Kuan P.L., Cheng J.J., Hung C.R. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J. 135:1998;862-867.
8. La Vecchia L., Bedogni F., Finocchi G., Mezzena G., Martini M., Sartori M., Castellani A., Soffiati G., Vincenzi M. Troponin T, troponin I, and creatine kinase-MB mass after elective coronary stenting. Coron Artery Dis. 7:1996;535-540.
9. Karim A.M., Shinn M., Oskarsson H., Windle J., Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol. 76:1995;521-523.
10. Abdelmeguid A.E., Topol E.J. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation. 94:1996;3369-3375.
11. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots a fundamental evaluation tool in clinical medicine . Clin Chem. 39:1993;561-577.
12. Califf R.M., Abdelmeguid A.E., Kuntz R.E., Popma J.J., Davidson C.J., Cohen E.A., Kleiman N.S., Mahaffey K.W., Topol E.J., Pepine C.J., Lipicky R.J., Granger C.B., Harrington R.A., Tardiff B.E., Crenshaw B.S., Bauman R.P., Zuckerman B.D., Chaitman B.R., Bittl J.A., Ohman E.M. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 31:1998;241-251.
13. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA. 277:1997;461-466.
14. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous interventions. Circulation. 94:1996;1528-1536.
15. Elliott J.M., Berdan L.G., Holmes D.R., Isner J.M., King S.B., Keeler G.P., Kearney M., Califf R.M., Topol E.J. One-year follow-up in the coronary angioplasty versus excisional atherectomy trial (CAVEAT I). Circulation. 91:1995;2158-2166.
16. Baim D.S., Cutlip D.E., Sharma S.K., Ho K.K., Fortuna R., Schreiber T.L., Feldman R.L., Shani J., Senerchia C., Zhang Y., Lansky A.J., Popma J.J., Kuntz R.E. Final results of the Balloon vs Optimal Atherectomy Trial. Circulation. 97:1998;322-331.
17. Oh J.K., Shub C., Ilstrup D.M., Reeder G.S. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 109:1985;1225-1231.
18. Polanczyk C.A., Lee T.H., Cook E.F., Walls R., Wybenga D., Printy-Klein G., Ludwig L., Guldbrandsen G., Johnson P.A. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol. 32:1998;8-14.
19. Topol E.J., Ferguson J.J., Weisman H.F., Tcheng J.E., Ellis S.G., Kleiman N.S., Ivanhoe R.J., Wang A.L., Miller D.P., Anderson K.M., Califf R.M. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA. 278:1997;479-484.